GLRX3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.981600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.623800E-01
Normal-vs-Stage2
4.403400E-01
Normal-vs-Stage3
6.164800E-01
Normal-vs-Stage4
7.612800E-01
Stage1-vs-Stage2
4.274800E-01
Stage1-vs-Stage3
6.828600E-01
Stage1-vs-Stage4
8.760000E-01
Stage2-vs-Stage3
9.826800E-01
Stage2-vs-Stage4
6.694600E-01
Stage3-vs-Stage4
8.248000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.421200E-01
Normal-vs-AfricanAmerican
2.845600E-01
Normal-vs-Asian
1.124990E-01
Caucasian-vs-AfricanAmerican
9.813600E-01
Caucasian-vs-Asian
1.726360E-01
AfricanAmerican-vs-Asian
2.150000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.042800E-01
Normal-vs-Female
6.297800E-01
Male-vs-Female
1.207630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.806800E-01
Normal-vs-Age(41-60Yrs)
2.810400E-01
Normal-vs-Age(61-80Yrs)
6.377800E-01
Normal-vs-Age(81-100Yrs)
3.432800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.418990E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.596000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.463800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.637500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.670600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.125400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.711000E-01
Normal-vs-Daily Drinker
5.713000E-01
Normal-vs-Weekly Drinker
3.837800E-01
Normal-vs-Occasional Drinker
2.929200E-01
Normal-vs-Social Drinker
8.340600E-01
Non Drinker-vs-Daily Drinker
9.709000E-01
Non Drinker-vs-Weekly Drinker
8.925400E-01
Non Drinker-vs-Occasional Drinker
3.357600E-01
Non Drinker-vs-Social Drinker
3.693000E-01
Daily Drinker-vs-Weekly Drinker
9.239400E-01
Daily Drinker-vs-Occasional Drinker
3.868400E-01
Daily Drinker-vs-Social Drinker
3.719400E-01
Weekly Drinker-vs-Occasional Drinker
4.263600E-01
Weekly Drinker-vs-Social Drinker
2.340400E-01
Occasional Drinker-vs-Social Drinker
7.003900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.531800E-01
Normal-vs-Grade 2
2.400000E-01
Normal-vs-Grade 3
2.534000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.565300E-04
Grade 1-vs-Grade 3
5.424500E-04
Grade 1-vs-Grade 4
9.531800E-01
Grade 2-vs-Grade 3
3.522600E-01
Grade 2-vs-Grade 4
2.400000E-01
Grade 3-vs-Grade 4
2.534000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.569200E-01
Normal-vs-NonDiabetic
4.989400E-01
Diabetic-vs-NonDiabetic
8.916200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.974400E-02
Normal-vs-NoPancreatitis
5.288600E-01
Pancreatitis-vs-NoPancreatitis
1.041420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.614400E-01
Normal-vs-N1
5.126000E-01
N0-vs-N1
8.021600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.168400E-02
Normal-vs-TP53-NonMutant
9.317600E-01
TP53-Mutant-vs-TP53-NonMutant
1.4812000004305E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
